Online Peptide DoctorsA guide to finding and understanding care

Plan the visit / Briefing

Questions to bring before agreeing to care

Copy the questions on this page into your notes. Bring them to a visit to ask about your health, the medicine, the pharmacy, the whole bill and help after the visit.

Product rules and prescribing guidance: as of September 26, 2026.

Begin with the health question

  • What are we trying to find out?

    Ask what the health review is meant to answer and what information is still missing.

  • What else could address this concern?

    Ask about other care options and why they may fit your goals.

  • What would lead to an in-person visit?

    Ask what the online visit cannot settle and who would help you see someone in person.

Ask what the product claim means

  • What is the ingredient, and is the medicine a pill or an injection?

    Keep the full name in your notes rather than a broad label such as “peptide therapy”.

  • Is this an approved or custom-made product?

    Compounding prepares or alters a medicine for an individual patient. These medicines have no Food and Drug Administration (FDA) approval and no FDA review of their quality, benefits or harms before sale.

  • Why is a custom-made product being discussed?

    Ask which medical need an approved product cannot meet. FDA says making a medicine to order may be appropriate for that need.

  • Who makes it and who supplies it to me?

    Ask for the pharmacy names so the records can be checked.

Ask about the plan beyond the first visit

  • How do I ask a follow-up question?

    Ask whether contact with whoever treats you remains available once the visit ends and once your medicine arrives.

  • How will we review the plan?

    Ask what the next conversation will cover and who explains any test results.

  • What does the full bill include?

    Ask about visits or membership, medicine, tests and delivery as separate items.

  • What are the cancellation terms?

    Ask what happens to each charge if you decline treatment or end the service.

Check the menu and the follow-up route

The Federation of State Medical Boards provides guidance to the state bodies that license doctors. Its guidance says a care decision needs more than a treatment selected from a menu.

Under its May 2026 guidance, patients need a route for asking follow-up questions; the enforceable rules come from states.

Reading notes